Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
139.97M | 135.10M | 146.74M | 141.79M | 87.00M | Gross Profit |
34.93M | -6.97M | -23.40M | 15.16M | 10.39M | EBIT |
7.64M | -27.32M | -41.64M | -13.05M | -11.60M | EBITDA |
17.09M | -17.45M | -30.00M | -1.62M | 3.23M | Net Income Common Stockholders |
8.35M | -26.76M | -37.80M | -14.71M | -12.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
66.24M | 12.16M | 4.34M | 7.53M | 5.45M | Total Assets |
168.70M | 128.47M | 112.59M | 132.69M | 143.93M | Total Debt |
4.03M | 7.47M | 15.95M | 35.16M | 47.49M | Net Debt |
-37.48M | 1.95M | 11.61M | 27.63M | 42.04M | Total Liabilities |
45.32M | 56.17M | 62.07M | 77.93M | 81.32M | Stockholders Equity |
123.38M | 72.62M | 50.53M | 54.77M | 62.62M |
Cash Flow | Free Cash Flow | |||
-4.13M | -37.77M | -17.30M | 1.12M | -9.89M | Operating Cash Flow |
-2.35M | -19.84M | -9.65M | 6.44M | -3.94M | Investing Cash Flow |
-7.51M | -18.52M | -7.17M | 3.31M | -15.95M | Financing Cash Flow |
44.71M | 39.55M | 13.63M | -7.67M | 10.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | HK$82.40M | 2.70 | 17.55% | ― | -12.07% | 34.63% | |
65 Neutral | $4.41B | 12.06 | 5.22% | 249.80% | 4.09% | -12.16% | |
56 Neutral | HK$121.68M | 10.37 | 7.24% | ― | 36.39% | ― | |
54 Neutral | HK$200.91M | 18.00 | 4.17% | ― | 2.61% | 8.70% | |
53 Neutral | HK$1.45B | ― | -30.10% | ― | 130.71% | 51.92% | |
41 Neutral | HK$62.96M | ― | -79.76% | ― | -1.68% | 49.77% | |
39 Underperform | HK$13.36M | ― | -8.84% | ― | -16.83% | 62.13% |